Cargando…
Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers: a prospective randomized controlled study
OBJECTIVE: This prospective randomized controlled pilot study aimed to find whether gelatin-thrombin matrix used as a tissue sealant (FloSeal) can prevent the occurrence of pelvic lymphocele in patients with gynecologic cancer who has undergone pelvic lymphadenectomy. METHODS: Each patient, who unde...
Autores principales: | Kim, Yun Hwan, Shin, Hyun Joo, Ju, Woong, Kim, Seung-Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391396/ https://www.ncbi.nlm.nih.gov/pubmed/28382800 http://dx.doi.org/10.3802/jgo.2017.28.e37 |
Ejemplares similares
-
Fibrin-thrombin sealant does not reduce lymphocele formation in patients with inguinofemoral lymphadenectomy for vulvar cancer
por: Saner, Flurina AM, et al.
Publicado: (2019) -
Distribution of lymphocele following lymphadenectomy in patients with gynecological malignancies
por: Song, Soo Youn, et al.
Publicado: (2020) -
Influence of Gelatin-Thrombin Matrix Tissue Sealant on Bacterial Colony Formation and Risk of Pelvic Infection
por: Jarrett, Michael J., et al.
Publicado: (2016) -
Thrombin based gelatin matrix and fibrin sealant mediated clot formation in the presence of clopidogrel
por: Dwyer, Joseph F, et al.
Publicado: (2014) -
Use of Floseal(®), a human gelatine-thrombin matrix sealant, in surgery: a systematic review
por: Echave, María, et al.
Publicado: (2014)